Add to ORKGThe Author(s) 2014. This article is published with open access at Springerlink.com Introduction: Psoriasis results in expenses to patients from many cost sources. Psoriasis treatments may result in considerable time and traveling costs, yet many studies fail to account for these costs. The objective of thi
The aim of this study was to examine the relationship between measures of disease severity and costs...
sociated with tremendous costs, particularly in patients not adequately controlled by conventional t...
Objective: To evaluate the impact of comorbidities on healthcare resource use (HRU), and direct and ...
Background : There are limited data available on the economical burden of psoriasis and its impact o...
P soriasis is a chronic, inflammatory skin condition that af-fects 3.2 % of the US population, and m...
The article associated with this page has been accepted for online publication and is in the fina...
Contains fulltext : 88933.pdf (publisher's version ) (Closed access)Background Alt...
Background: Psoriasis is a chronic inflammatory disease of the skin that has a major effect on an in...
Estimates of direct and indirect costs of psoriasis are limited. The aim of this study was to estima...
Background: Psoriasis is a chronic disease that can have accompanying comorbidities including arthri...
Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psor...
Abstract: Background: Psoriasis is a chronic, immune mediated inflammatory condition that affects a...
Background: Generalized pustular psoriasis (GPP), which can occur with or without psoriasis vulgaris...
Psoriasis (PSO) and psoriatic arthritis (PsA) are two related chronic inflammatory diseases. A propo...
Background: According to current guidelines the cost of productivity loss should be considered in ph...
The aim of this study was to examine the relationship between measures of disease severity and costs...
sociated with tremendous costs, particularly in patients not adequately controlled by conventional t...
Objective: To evaluate the impact of comorbidities on healthcare resource use (HRU), and direct and ...
Background : There are limited data available on the economical burden of psoriasis and its impact o...
P soriasis is a chronic, inflammatory skin condition that af-fects 3.2 % of the US population, and m...
The article associated with this page has been accepted for online publication and is in the fina...
Contains fulltext : 88933.pdf (publisher's version ) (Closed access)Background Alt...
Background: Psoriasis is a chronic inflammatory disease of the skin that has a major effect on an in...
Estimates of direct and indirect costs of psoriasis are limited. The aim of this study was to estima...
Background: Psoriasis is a chronic disease that can have accompanying comorbidities including arthri...
Background: Psoriasis is associated with significant economic burdens. Data regarding costs for psor...
Abstract: Background: Psoriasis is a chronic, immune mediated inflammatory condition that affects a...
Background: Generalized pustular psoriasis (GPP), which can occur with or without psoriasis vulgaris...
Psoriasis (PSO) and psoriatic arthritis (PsA) are two related chronic inflammatory diseases. A propo...
Background: According to current guidelines the cost of productivity loss should be considered in ph...
The aim of this study was to examine the relationship between measures of disease severity and costs...
sociated with tremendous costs, particularly in patients not adequately controlled by conventional t...
Objective: To evaluate the impact of comorbidities on healthcare resource use (HRU), and direct and ...